Brinker Capital Investments’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-29,261
| Closed | -$1.27M | – | 1774 |
|
|
2023
Q3 | $1.27M | Buy |
29,261
+6,944
| +31% | +$302K | 0.02% | 816 |
|
|
2023
Q2 | $806K | Sell |
22,317
-729
| -3% | -$26.3K | 0.01% | 1035 |
|
|
2023
Q1 | $857K | Buy |
23,046
+359
| +2% | +$13.3K | 0.01% | 942 |
|
|
2022
Q4 | $1.03M | Buy |
22,687
+5,925
| +35% | +$268K | 0.02% | 721 |
|
|
2022
Q3 | $1.17M | Buy |
16,762
+2,692
| +19% | +$188K | 0.02% | 647 |
|
|
2022
Q2 | $945K | Buy |
14,070
+6,882
| +96% | +$462K | 0.02% | 767 |
|
|
2022
Q1 | $591K | Buy |
+7,188
| New | +$591K | 0.01% | 990 |
|